Viewing nowCombinationDuo Telmisartan/Atorvastatin Tablet 80/20 mg
Telmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hankook HyuTex Pharmaceutical Co., Ltd.

MFDS item code 202005518 · Approved 2020.07.29 · Insurance code 649105030
(Reduction of high blood pressure and cardiovascular disease risk) and (Improvement of hypercholesterolemia)
This medication is used for patients who require simultaneous treatment with telmisartan and atorvastatin. Telmisartan is primarily used for the treatment of essential hypertension and helps to reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in patients over 55 years old who are at high risk for cardiovascular disease or who cannot use ACE inhibitors. Atorvastatin is used in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise are not sufficient, lowering total cholesterol and LDL cholesterol levels to delay the progression of atherosclerosis. Additionally, it is used as an adjunct to dietary therapy in patients with hypercholesterolemia and abnormal beta-lipoproteinemia. In high-risk populations with cardiovascular risk factors, it helps to reduce the risk of stroke, myocardial infarction, and vascular revascularization. This medication is therefore used to manage both hypertension and hyperlipidemia simultaneously and improve cardiovascular health.
Telmisartan: For adults with essential hypertension, it is recommended to take 40 mg orally once daily; a dosage of 20 mg daily may also be effective for some patients. If necessary, the dosage can be increased up to 80 mg once daily. To reduce the risk of cardiovascular disease, it is recommended to take 80 mg orally once daily; the effects of doses below 80 mg are unknown. Patients with liver impairment should not exceed a dose of 40 mg once daily.
This medication poses a significant risk of serious harm or death to the fetus and newborn if taken during pregnancy, hence treatment should be stopped immediately upon confirmation of pregnancy. Women who are pregnant or breastfeeding, and women of childbearing age who are not using appropriate contraception should not take this medication. Patients with severe liver impairment, bile duct obstruction, active liver disease, myopathy, hereditary angioedema, or severe renal impairment should also avoid using this medication. Elderly patients, those with hyperkalemia, and those with mild to moderate liver dysfunction should use this medication with caution, with regular monitoring of liver function tests and muscle-related symptoms. If symptoms such as myalgia, muscle weakness, or muscle cramps occur, consult a physician immediately, and check for muscle damage through blood tests. This medication may interact with other specific medications, so always inform healthcare providers of other medications being taken. This medication is primarily metabolized in the liver, and regular testing of liver enzyme levels should be conducted if liver function is impaired. It should not be used during pregnancy or breastfeeding, particularly in women who could become pregnant, who should use appropriate contraceptive methods. Safety and effectiveness in children have not been established; therefore, it is not recommended for pediatric use. In case of overdose, symptoms may include hypotension, dizziness, and acute renal failure, so immediate medical attention is required. This medication may cause drowsiness or dizziness; caution should be exercised when driving or operating hazardous machinery. Keep out of reach of children and do not store in other containers for safety.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, cough accompanied by fever-related respiratory abnormalities, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, vision disturbances, paralysis, dark urine
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, and should therefore be stored in a tightly closed container. The suitable storage temperature is room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the efficacy and safety of the medication.
White oval film-coated tablet
30 tablets/box [10 tablets/PTP×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hankook HyuTex Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.